https://doi.org/10.1177/17562864221147743
H
Hongbing Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
2.6K
Citations
27
h-index
57
i10-index
Hongbing Liu is an academic researcher from Tulane University. The author has contributed to research in topics: Acute Ischemic Stroke Management & Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations. The author has an h-index of 27, co-authored 112 publications.
ORCID: 0000-0001-7718-3288Papers by this author
worksEarly neurological deterioration in patients with acute ischemic stroke: a prospective multicenter cohort study
2023 · Therapeutic Advances in Neurological Disorders · 69 citations
PaO2/FiO2 and IL-6 are risk factors of mortality for intensive care COVID-19 patients
2021 · Scientific Reports · 62 citations
https://doi.org/10.1038/s41598-021-86676-3
Risk factors for physical disability in patients with leprosy disease in Yunnan, China: Evidence from a retrospective observational study
2021 · PLoS neglected tropical diseases · 29 citations
https://doi.org/10.1371/journal.pntd.0009923
Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function
2012 · Retrovirology · 25 citations
https://doi.org/10.1186/1742-4690-9-90
Iron accumulation and lipid peroxidation: implication of ferroptosis in diabetic cardiomyopathy
2023 · Diabetology & Metabolic Syndrome · 22 citations
https://doi.org/10.1186/s13098-023-01135-5
Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
2024 · BMC Infectious Diseases · 22 citations
https://doi.org/10.1186/s12879-023-08754-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat